Given the current lack of targeted drugs for SERPINB3, nanobiotechnology has shed new light on the application of new therapeutic targets for cancer.[47] We can precisely deliver siRNA to the tumor and efficiently knock down the target gene by the EPR effect with NPs. This evidence concerns the gene SERPINB3 and neoplasm.